AAAAAA

   
Results: 1-14 |
Results: 14
USE OF INTERLEUKIN-2 IN IMMUNOTHERAPY OF HUMAN-IMMUNODEFICIENCY-VIRUSINFECTION
Authors: REIER A MITSUYASU RT
Citation: A. Reier et Rt. Mitsuyasu, USE OF INTERLEUKIN-2 IN IMMUNOTHERAPY OF HUMAN-IMMUNODEFICIENCY-VIRUSINFECTION, Biodrugs, 10(3), 1998, pp. 215-225
MANAGEMENT OF AIDS-ASSOCIATED KAPOSIS-SARCOMA - A MULTIDISCIPLINARY PERSPECTIVE - PROCEEDINGS OF A ROUNDTABLE SYMPOSIUM, MARCH 10, 1997, NEW-YORK
Authors: VONROENN JH KROWN SE BENSON CA MITSUYASU RT FRIEDMANKIEN AE SCADDEN DT STELZER KJ
Citation: Jh. Vonroenn et al., MANAGEMENT OF AIDS-ASSOCIATED KAPOSIS-SARCOMA - A MULTIDISCIPLINARY PERSPECTIVE - PROCEEDINGS OF A ROUNDTABLE SYMPOSIUM, MARCH 10, 1997, NEW-YORK, Oncology, 12(2), 1998, pp. 9-24
ACTIVITY OF THE SOFT GELATIN FORMULATION OF SAQUINAVIR IN COMBINATIONTHERAPY IN ANTIRETROVIRAL-NAIVE PATIENTS
Authors: MITSUYASU RT SKOLNIK PR COHEN SR CONWAY B GILL MJ JENSEN PC PULVIRENTI JJ SLATER LN SCHOOLEY RT THOMPSON MA TORRES RA TSOUKAS CM
Citation: Rt. Mitsuyasu et al., ACTIVITY OF THE SOFT GELATIN FORMULATION OF SAQUINAVIR IN COMBINATIONTHERAPY IN ANTIRETROVIRAL-NAIVE PATIENTS, AIDS, 12(11), 1998, pp. 103-109
AIDS CLINICAL-TRIALS GROUP-STUDY-094 - A PHASE I II TRIAL OF ABV CHEMOTHERAPY WITH ZIDOVUDINE AND RECOMBINANT HUMAN GM-CSF IN AIDS-RELATED KAPOSIS-SARCOMA/
Authors: GILL PS MITSUYASU RT MONTGOMERY T HUANG J CABRIALES S TESTA M ESPINA BM MILES SA
Citation: Ps. Gill et al., AIDS CLINICAL-TRIALS GROUP-STUDY-094 - A PHASE I II TRIAL OF ABV CHEMOTHERAPY WITH ZIDOVUDINE AND RECOMBINANT HUMAN GM-CSF IN AIDS-RELATED KAPOSIS-SARCOMA/, The cancer journal from Scientific American, 3(5), 1997, pp. 278-283
A PHASE-II STUDY OF RECOMBINANT HUMAN INTERFERON-(ALPHA-2A) AND ZIDOVUDINE IN PATIENTS WITH AIDS-RELATED KAPOSIS-SARCOMA
Authors: FISCHL MA FINKELSTEIN DM HE WL POWDERLY WG TRIOZZI PL STEIGBIGEL RT MAIEWSKI S DALE E MILLAR L GOULD M RATNER L PARA MF GOWER R TENZLER R FUHRER J MILDVAN D MALAMUD SC DEZUBE B CHAPMAN B CRUMPACKER C ISRAEL HB FEINBERG J HOOD A RAINES CP MILES SA MITSUYASU RT CARDEN J MCMAHON D PAZIN G SCHULOF RS CORTLESS JL LELACHEUR SF EHMANN WC EYSTER ME MCKINLEY GF GRIECO MH KOLATCH B BENNETT JM RYBAK ME CHEESEMAN SH KOUP RA DIAMOND A
Citation: Ma. Fischl et al., A PHASE-II STUDY OF RECOMBINANT HUMAN INTERFERON-(ALPHA-2A) AND ZIDOVUDINE IN PATIENTS WITH AIDS-RELATED KAPOSIS-SARCOMA, Journal of acquired immune deficiency syndromes and human retrovirology, 11(4), 1996, pp. 379-384
CHEMOTHERAPY OF AIDS-RELATED KAPOSIS-SARCOMA
Authors: LEE FC MITSUYASU RT
Citation: Fc. Lee et Rt. Mitsuyasu, CHEMOTHERAPY OF AIDS-RELATED KAPOSIS-SARCOMA, Hematology/oncology clinics of North America, 10(5), 1996, pp. 1051
UPDATE ON THE TREATMENT OF KAPOSIS-SARCOMA
Authors: MITSUYASU RT
Citation: Rt. Mitsuyasu, UPDATE ON THE TREATMENT OF KAPOSIS-SARCOMA, AIDS, 10, 1996, pp. 82-82
RANDOMIZED TRIAL OF MNRGP120 HIV-1 VACCINE IN SYMPTOMLESS HIV-1 INFECTION
Authors: ERON JJ ASHBY MA GIORDANO MF CHERNOW M REITER WM DEEKS SG LAVELLE JP CONANT MA YANGCO BG PATE PG TORRES RA MITSUYASU RT TWADDELL T
Citation: Jj. Eron et al., RANDOMIZED TRIAL OF MNRGP120 HIV-1 VACCINE IN SYMPTOMLESS HIV-1 INFECTION, Lancet, 348(9041), 1996, pp. 1547-1551
COMBINATION AND MONOTHERAPY WITH ZIDOVUDINE AND ZALCITABINE IN PATIENTS WITH ADVANCED HIV DISEASE
Authors: FISCHL MA STANLEY K COLLIER AC ARDUINO JM STEIN DS FEINBERG JE ALLAN JD GOLDSMITH JC POWDERLY WG RAINES CP MAYJO KJ KERULY JC CRAVEN D HIRSHORN L HIRSCH MS JAYAWEERA DT YOUNG SW PATRONEREESE J BRETTLER D SPERBER K GERITS P SEREMETIS S GILL JC GELB LD MCGUIRE ML STIFFLER T LEDERMAN MM CAREY JT WALLACE M MACARTHUR RD BERGE P MILDVAN D COREY L COOMBS RW CUMMINGS DK SCHOOLEY RT RAY MG WAITE V KURITZKES DR FUHRER J TENZLER RJ DONLON W VANDERHORST CM TROIANI L HORTON J LANE TW MURPHY RR PHAIR JP KESSLER HA BENSON CA ROSENWALD V YONREN S VALENTINE F HASLETT P MITSUYASU RT GUERRO M GOETZ MB MATHISEN GE FRAME PT BRINKDOPKE J POWELL T HOELLE M MERIGAN TC SHAFER R CAIN P FESSELL J HENRY K RHAME F CHRISTENSON J STRYKE D ZINGMAN B KAHL P SOEIRO R CHOI YS REICHMAN RL REID J BLAIR DC STEIGBIGEL RT HEWITT RG CAMERON ML DONNELLY MA PACKARD MV BARTLETT JA FIFE KH ZWICKL BW BORUM J BURACK JH DYBECK KA COLEMAN RL JOHNSON WR MCKINLEY GF GRIECO MH KOLATCH BR SEPKOWITZ K PONTICELLO L GIORDANO MF MURRAY HW GOCKE DJ FASS RJ PARA MF STERN JS DREW LJ SPECTOR SA HAVLIR DV NUFFER KL RICHMAN DD CONNOR EM KLOSER PC PICARDI JM VANMATERMINER C LEEDOM JM HOLTOM PD RICHARDSON W EHMANN WC ZURLO JJ KREHER M EYSTER ME HYSLOP NE MUSHATT DM HOADLEY DJ ZACHARY JA SIMON GL PARENTI DM LELACHEUR S SCHUCK S HO MT MCMAHON DK PAZIN GJ ROSENER R CHEESEMAN SH MANGINI LA SANDS MG KAZIAL K JONES G PETTINELLI CB LANDRY B MARTINEZ AI
Citation: Ma. Fischl et al., COMBINATION AND MONOTHERAPY WITH ZIDOVUDINE AND ZALCITABINE IN PATIENTS WITH ADVANCED HIV DISEASE, Annals of internal medicine, 122(1), 1995, pp. 24-32
PHENOTYPICALLY DEFINED MEMORY CD4+ CELLS ARE NOT SELECTIVELY DECREASED IN CHRONIC HIV DISEASE
Authors: CHOU CC GUDEMAN V OROURKE S ISACESCU V DETELS R WILLIAMS GJ MITSUYASU RT GIORGI JV
Citation: Cc. Chou et al., PHENOTYPICALLY DEFINED MEMORY CD4+ CELLS ARE NOT SELECTIVELY DECREASED IN CHRONIC HIV DISEASE, Journal of acquired immune deficiency syndromes, 7(7), 1994, pp. 665-675
IMPROVED SURVIVAL FOR PATIENTS WITH AIDS-RELATED KAPOSIS-SARCOMA
Authors: MILES SA WANG HJ ELASHOFF R MITSUYASU RT
Citation: Sa. Miles et al., IMPROVED SURVIVAL FOR PATIENTS WITH AIDS-RELATED KAPOSIS-SARCOMA, Journal of clinical oncology, 12(9), 1994, pp. 1910-1916
PHASE-I AIDS CLINICAL-TRIALS GROUP(075) STUDY OF ADRIAMYCIN, BLEOMYCIN AND VINCRISTINE CHEMOTHERAPY WITH ZIDOVUDINE IN THE TREATMENT OF AIDS-RELATED KAPOSIS-SARCOMA
Authors: GILL PS MILES SA MITSUYASU RT MONTGOMERY T MCCARTHY S ESPINA BM FELDSTEIN M LEVINE AM
Citation: Ps. Gill et al., PHASE-I AIDS CLINICAL-TRIALS GROUP(075) STUDY OF ADRIAMYCIN, BLEOMYCIN AND VINCRISTINE CHEMOTHERAPY WITH ZIDOVUDINE IN THE TREATMENT OF AIDS-RELATED KAPOSIS-SARCOMA, AIDS, 8(12), 1994, pp. 1695-1699
THE DURATION OF ZIDOVUDINE BENEFIT IN PERSONS WITH ASYMPTOMATIC HIV-INFECTION - PROLONGED EVALUATION OF PROTOCOL-019 OF THE AIDS-CLINICAL-TRIALS-GROUP
Authors: VOLBERDING PA LAGAKOS SW GRIMES JM STEIN DS BALFOUR HH REICHMAN RC BARTLETT JA HIRSCH MS PHAIR JP MITSUYASU RT FISCHL MA SOEIRO R
Citation: Pa. Volberding et al., THE DURATION OF ZIDOVUDINE BENEFIT IN PERSONS WITH ASYMPTOMATIC HIV-INFECTION - PROLONGED EVALUATION OF PROTOCOL-019 OF THE AIDS-CLINICAL-TRIALS-GROUP, JAMA, the journal of the American Medical Association, 272(6), 1994, pp. 437-442
ACTIVATED PHENOTYPE OF CIRCULATING HIV-SPECIFIC CD8-CELLS( CYTOTOXIC T)
Authors: GIORGI JV HO HN MITSUYASU RT
Citation: Jv. Giorgi et al., ACTIVATED PHENOTYPE OF CIRCULATING HIV-SPECIFIC CD8-CELLS( CYTOTOXIC T), Journal of cellular biochemistry, 1993, pp. 78-78
Risultati: 1-14 |